Seeing Is Believing

Currently out of the existing stock ratings of Michael Leuchten, 12 are a BUY (30.77%), 22 are a HOLD (56.41%), 5 are a SELL (12.82%).
Analyst Michael Leuchten, currently employed at JEFFERIES, carries an average stock price target met ratio of 83.33% that have a potential upside of 19.57% achieved within 231 days. Previously, Michael Leuchten worked at UBS, BARCLAYS, TD COWEN.
Michael Leuchten’s has documented 68 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Basic Materials, Consumer Cyclical sectors.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 27-Oct-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 2/11/2021. The price target of $34.53 was fulfilled within 1 day with a profit of $0.59 (1.74%) receiving and performance score of 17.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$105
$-83.41 (-44.27%)
$95
Buy Since 05-Sep-2023
$108.5
$-79.91 (-42.41%)
$91.7
Hold Since 12-Feb-2025
What Year was the first public recommendation made by Michael Leuchten?